Bristol-Myers Squibb Company Names David I. Johnson President Of ConvaTec
Advertisement
Bristol-Myers Squibb Company announced that David I. Johnson has been named President, ConvaTec. As president, Mr. Johnson will have responsibility for all aspects of the worldwide ConvaTec business. He will be based at ConvaTec global headquarters in Skillman, New Jersey. ConvaTec, a Bristol-Myers Squibb Company, is a manufacturer of ostomy and wound therapeutic products.
After joining Bristol-Myers Squibb Company in 1996, Mr. Johnson held positions of increasing leadership responsibility for Zimmer in Canada and Europe. In 2000, he became part of the ConvaTec business as Vice President of North America. Mr. Johnson's most recent position with ConvaTec was Senior Vice President, Global Commercial Operations.
Most read news
Organizations
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Zeon Increases Global Nitrile Capacity
Samsung Total selects Basell's Spherizone technology for a new 250 KT PP plant
Catalyst Technology Wins Again for Avecia Partnership
Epicyte and Dow Enter a Research and Development Collaboration with Centocor for Production of a Therapeutic Monoclonal Antibody
Environmental Management System - ISO14001 accreditation for Malvern Instruments

Hanns-Peter Knaebel as the Röchling Group’s New CEO
New magnetic carbon composites for biological and environmental applications - Scientists at Leibniz Institute for Agricultural Engineering in Potsdam and Humboldt University Berlin developed a simple process for direct synthesis of magnetic carbon composites through hydrotherma
Andersen-Tawil_syndrome
Cerium(IV)_oxide
Californium

'Nano inks' could passively control temperature in buildings, cars - First 'phase-change' inks developed that could transform the way we heat and cool
